NCT05675098View on ClinicalTrials.gov

Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2027

Conditions

Neurodevelopmental DisordersCerebral Palsy

Interventions

DRUG

Methylphenidate

This medication is a psychostimulant medication and is usually prescribed for individuals with Attention-Deficit/Hyperactivity Disorder to manage ADHD behavioral symptoms

DRUG

Modafinil

This medication is a Central Nervous System stimulant and is usually used to treat neurological conditions, including Narcolepsy

OTHER

Placebo

Participant will receive placebo tablets (Methylphenidate and Modafinil shape)

Trial Locations (1)

Unknown

Physical Medicine and Rehabilitation Hospital, Kuwait City

All Listed Sponsors

lead

Kuwait University

OTHER

NCT05675098 - Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy | Biotech Hunter | Biotech Hunter